Holly Lee
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 24
- Multiple Myeloma Research and Treatments 22
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 10
- Protein Degradation and Inhibitors 4
- Co-authors
- Nizar J. Bahlis (33 shared papers)Paola Neri (32 shared papers)Noémie Leblay (17 shared papers)Sungwoo Ahn (15 shared papers)Elie Barakat (12 shared papers)Jason Tay (13 shared papers)Ranjan Maity (9 shared papers)Peter Duggan (12 shared papers)
- Journals
- Blood (18 papers)Canadian Family Physician (2 papers)Amyloid (1 paper)Canadian Journal of Emergency Medicine (1 paper)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Holly Lee
35 papers receiving 210 citations
Peers
Comparison fields: 5 of 35
- Hematology 102
- Oncology 96
- Radiology, Nuclear Medicine and Imaging 35
- Molecular Biology 91
- Nephrology 8
Countries citing papers authored by Holly Lee
This map shows the geographic impact of Holly Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Lee more than expected).
Fields of papers citing papers by Holly Lee
This network shows the impact of papers produced by Holly Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Lee. The network helps show where Holly Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Holly Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 26 | |
| 2 | 2024 | 22 | |
| 3 | 2023 | 17 | |
| 4 | 2018 | 13 | |
| 5 | 2023 | 12 | |
| 6 | 2024 | 11 | |
| 7 | 2022 | 11 | |
| 8 | 2023 | 10 | |
| 9 | 2019 | 9 | |
| 10 | 2021 | 8 | |
| 11 | 2017 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2023 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Holly Lee
Holly Lee is a scholar working on Hematology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 40 papers that have together received 211 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (22 papers), CAR-T cell therapy research (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Peptidase Inhibition and Analysis (5 papers), Protein Degradation and Inhibitors (4 papers), T-cell and B-cell Immunology (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Hematology (102 citations), Oncology (96 citations), Radiology, Nuclear Medicine and Imaging (35 citations), Molecular Biology (91 citations) and Nephrology (8 citations). Holly Lee has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Nizar J. Bahlis, Paola Neri, Noémie Leblay, Sungwoo Ahn, Elie Barakat, Jason Tay, Ranjan Maity, Peter Duggan, Rémi Tilmont and Francesco Maura. Their work appears in journals such as Blood, Canadian Family Physician, Amyloid, Canadian Journal of Emergency Medicine and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.